-TheWire.in Professor Andrew Pollard tells Karan Thapar why India's 12-16 week Covishield gap makes sense, but refutes claim a single dose AstraZeneca vaccine is likely soon. The Chief Investigator of AstraZeneca and the Director of the Oxford Vaccine Group has, in this interview, addressed the present controvery over how long the gap between two doses of Covishield should be, clearly endorsing the Centre’s present policy of a 12-16 week gap. Professor Sir Andrew...

More »